Share on LinkedInShare on LinkedIn

ARTICLE · 13 OCTOBER 2026

Beyond The Patent: Rethinking Innovation Protection In The Medtech Sector

For many medical technology companies, a patent is the natural starting point when considering intellectual property protection for a new product.

United KingdomIntellectual Property

For many medical technology companies, a patent is the natural starting point when considering intellectual property protection for a new product.

The technology is new, the invention is technical and the commercial instinct is therefore to ask: what can we patent?

But that question may be too narrow.

The recently modernised EU Registered Design regime provides Medtech companies with an opportunity to think more broadly about the IP protection available for their products.

The new regime expressly accommodates animation and movement, digital products such as graphical user interfaces, and dynamic representations including 3D and video formats.

For Medtech companies, these changes are potentially significant. They create greater scope to protect aspects of a product that may be commercially important, but which are not necessarily captured by patent protection.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from